Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We incorporated in March 1991 as a California corporation and changed our state of incorporation to Delaware in May 1997. We changed our name from SuperGen, Inc. to Astex Pharmaceuticals, Inc. in September 2011. Our executive offices are located at 4140 Dublin Blvd., Suite 200, Dublin, CA, 94568 and our telephone number at that address is (925) 560-0100. We maintain a website on the internet at www.astx.com. This is a textual reference only. We do not incorporate the information on our website into this annual report on Form 10-K, and you should not consider any information on, or that can be accessed through, our website as part of this annual report on Form 10-K. Overview We are dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology and hematology. We are developing a pipeline of novel medicines for partnership with leading pharmaceutical companies. ... More ...
Analyst Info |
|
| Annual EPS Est: | $ |
| Quarterly EPS Est: | |
| PEG Ratio: | -.02 |
|
Mean Recommendation: View Summary / View All |
1.5 |
Data is provided by Zacks Investment Research
